Gadgeel SM - Search Results

1

Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer.

Nagasaka M, Gadgeel SM. Nagasaka M, et al. Among authors: gadgeel sm. Expert Rev Anticancer Ther. 2018 Jan;18(1):63-70. doi: 10.1080/14737140.2018.1409624. Epub 2017 Nov 26. Expert Rev Anticancer Ther. 2018. PMID: 29168933 Free PMC article. Review.

2

Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.

Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M. Kalemkerian GP, et al. J Natl Cancer Inst. 1995 Nov 15;87(22):1674-80. doi: 10.1093/jnci/87.22.1674. J Natl Cancer Inst. 1995. PMID: 7473815

3

Lung cancer in patients < 50 years of age: the experience of an academic multidisciplinary program.

Gadgeel SM, Ramalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE, Kalemkerian GP. Gadgeel SM, et al. Chest. 1999 May;115(5):1232-6. doi: 10.1378/chest.115.5.1232. Chest. 1999. PMID: 10334132

4

Biochemotherapy of melanoma.

Flaherty LE, Gadgeel SM. Flaherty LE, et al. Among authors: gadgeel sm. Semin Oncol. 2002 Oct;29(5):446-55. doi: 10.1053/sonc.2002.35239. Semin Oncol. 2002. PMID: 12407509 Review.

5

Cost-effectiveness and lung cancer clinical trials.

Du W, Reeves JH, Gadgeel S, Abrams J, Peters WP. Du W, et al. Cancer. 2003 Oct 1;98(7):1491-6. doi: 10.1002/cncr.11659. Cancer. 2003. PMID: 14508837 Free article.

6

Predictors of enrollment in lung cancer clinical trials.

Du W, Gadgeel SM, Simon MS. Du W, et al. Among authors: gadgeel sm. Cancer. 2006 Jan 15;106(2):420-5. doi: 10.1002/cncr.21638. Cancer. 2006. PMID: 16342295 Free article.

7

A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy.

Riely GJ, Gadgeel S, Rothman I, Saidman B, Sabbath K, Feit K, Kris MG, Rizvi NA. Riely GJ, et al. Lung Cancer. 2007 Feb;55(2):181-5. doi: 10.1016/j.lungcan.2006.10.002. Epub 2006 Nov 7. Lung Cancer. 2007. PMID: 17092603 Clinical Trial.

8

Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?

Wozniak AJ, Gadgeel SM. Wozniak AJ, et al. Among authors: gadgeel sm. Oncology (Williston Park). 2007 Feb;21(2):163-71; discussion 171, 174, 179-82. Oncology (Williston Park). 2007. PMID: 17396481 Free article. Review.

9

Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC).

Gadgeel SM, Ruckdeschel JC, Heath EI, Heilbrun LK, Venkatramanamoorthy R, Wozniak A. Gadgeel SM, et al. J Thorac Oncol. 2007 Apr;2(4):299-305. doi: 10.1097/01.JTO.0000263712.61697.69. J Thorac Oncol. 2007. PMID: 17409801 Free article. Clinical Trial.

10

Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancer.

Wozniak AJ, Belzer K, Heilbrun LK, Kucuk O, Gadgeel S, Kalemkerian GP, Venkatramanamoorthy R, Kraut MJ. Wozniak AJ, et al. Clin Lung Cancer. 2007 Mar;8(5):313-8. doi: 10.3816/CLC.2007.n.010. Clin Lung Cancer. 2007. PMID: 17562230 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters